Optimization implementation method for intracellular synthesis of bacterial nanocellulose

By knocking out relevant genes and overexpressing the bglB_2 gene, the secretion of extracellular BCs of bacteria is blocked, and the efficient intracellular synthesis and purification of bacterial nanocellulose is achieved, which solves the problems of low extracellular production efficiency and structural damage, and significantly improves the cells Growth and yield.

CN118909900APending Publication Date: 2024-11-08SHANGHAI JIAOTONG UNIV +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410993502.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-24
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

During the extracellular production of bacterial nanocellulose, bacteria are wrapped and wrapped, resulting in slow growth and low production efficiency, and traditional purification methods can damage the cellulose structure.

Method used

By knocking out the acsC gene related to BC secretion and overexpressing the bglB_2 gene, extracellular BC secretion is blocked, and efficient synthesis and simple purification of intracellular BC is achieved, avoiding structural damage under alkaline solutions and high temperature conditions.

Benefits of technology

The growth of bacterial cells and intracellular BC yield were significantly improved, and the production efficiency was improved. The efficient purification of BC was achieved through ethanol extraction and anthraone sulfuric acid method, avoiding the structural damage problem in traditional methods.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118909900A_ABST
    Figure CN118909900A_ABST
Patent Text Reader

Abstract

The invention relates to an optimization realization method for intracellular synthesis of bacterial nano-cellulose, which comprises the following steps of: preparing gluconacetobacter xylinus acsC132 + bglB2 for producing the intracellular bacterial nano-cellulose, and the preservation number of the gluconacetobacter xylinus is CGMCC (China General Microbiological Culture Collection Center) No.31120. On the basis of the engineering bacterium, the blocking of extracellular BC secretion is realized, the intracellular BC yield is obviously improved, the problems of long production period and low production efficiency caused by wrapping and winding thalli by the BC in extracellular production are solved, and the engineering bacterium is expected to become a novel large-scale production mode.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a technology in the field of genetic engineering, in particular to an optimization method for realizing the intracellular synthesis of bacterial nanocellulose. Background Art

[0002] Bacterial nanocellulose (BC) is an extracellular insoluble polysaccharide synthesized by microorganisms. Its polymerization, secretion, assembly and crystallization processes are regulated by BC synthases (BcsA, BcsB, BcsC, BcsD) and some auxiliary proteins (BcsH, CmcAx, BglX) in microbial cells. Komagataeibacterxylinus is the most studied microorganism with the strongest BC synthesis ability and is a strictly aerobic bacterium. In the fermentation medium, the BC synthesized by K.xylinus will intertwine and wrap the cells in the fiber network, resulting in slow growth and gradual death of the bacteria. Such fermentation characteristics seriously affect the growth of bacteria and the synthesis of the product BC, and there are problems with low BC production and efficiency. In addition, the current BC purification method is mainly to remove impurities by multiple washings with deionized water, and then use 0.05-0.25M alkaline solution to remove the bacteria at high temperature. However, in alkaline solution, the glucose group at the end of BC will be cleaved; if it is under high temperature conditions, alkaline hydrolysis reaction will occur, further destroying the polysaccharide structure and causing its degree of polymerization to decrease. Summary of the invention

[0003] The present invention aims at the problem that the prior art produces BC wrapped around the thallus, resulting in a long production cycle and low production efficiency. The present invention proposes an optimized method for the intracellular synthesis of bacterial nanocellulose, including the knockout of BC secretion-related genes and the overexpression of synthesis-related genes, which avoids the dilemma that after BC is secreted outside the cell, cell growth is blocked and the increase in yield is limited, and solves the problem that the extracellular production of BC wraps around the thallus, resulting in low production efficiency. In addition, after the dynamic fermentation is completed, a simple solvent purification method for intracellular BC can be used to avoid the destruction of BC structural properties by using alkali boiling conditions. Therefore, the present method is a new and efficient way to produce BC.

[0004] The present invention is achieved through the following technical solutions:

[0005] The present invention relates to a xylinobacter △acsC_132+bglB_2 for producing intracellular bacterial nanocellulose, which is classified as Komagataeibacterxylinus, has a preservation number of CGMCC No.31120, and is currently preserved in the Institute of Microbiology, Chinese Academy of Sciences (No. 3, Yard No. 1, Beichen West Road, Chaoyang District, Beijing), with a preservation date of July 1, 2024.

[0006] The xylinus Gluconobacter △acsC_132+bglB_2 no longer secretes BC outside the cell, and compared with the starting strain xylinus Gluconobacter (K. xylinus ATCC 53524), the cell growth rate is significantly improved.

[0007] The cell growth amount is measured by the following method:

[0008] 1) The cell growth of △acsC_132+bglB_2 was determined by turbidimetry. The fermentation broth was diluted to an appropriate multiple and the optical density (OD) of the bacterial suspension was determined by a spectrophotometer. 600 And make a growth curve.

[0009] 2) First, use cellulase to enzymolyze the extracellular BC synthesized by K.xylinusATCC 53524 strain, and then use turbidimetry to determine its cell growth. Accurately weigh 21.01g of monohydrated citric acid and 29.41g of sodium citrate, and dilute them to 1L of distilled water respectively; take 828mL of 0.1mol / L citric acid solution and 972mL of 0.1mol / L sodium citrate solution, mix them evenly, and prepare a citric acid-sodium citrate buffer solution with a pH of 4.8; take 18g of cellulase (McLean, 10000U / g) and dissolve it in 1.8L of buffer solution, and filter it with a 0.22μm filter membrane to remove the insoluble matter in the cellulase. 50 mL of cellulase solution was added to a 250 mL conical flask containing 50 mL of fermentation broth to make a final cellulase concentration of 50 U / mL. The fermentation broth was subjected to enzymolysis at 55°C and 180 rpm for 12-24 h. For the fermentation broth that was not fully hydrolyzed, it was centrifuged at 3000 g for 10 min. 25 mL of cellulase solution and 25 mL of distilled water were added to the precipitate. The enzymolysis was continued at 55°C and 180 rpm. The BC enzymolysis was observed under a microscope until it was completely hydrolyzed. The OD was measured. 600 And make a growth curve.

[0010] The present invention relates to a method for realizing the above-mentioned xylinobacter △acsC_132+bglB_2, wherein xylinobacter △acsC_132+bglB_2 is constructed by using xylinobacter △acsC_132 (K.xylinusATCC 53524) as a starting strain, knocking out acsC_1, acsC_2 and acsC_3 genes that may be related to BC secretion to obtain a △acsC_132 strain that produces intracellular BC; and then overexpressing the bglB_2 gene on the basis of △acsC_132 to obtain a strain, which specifically comprises:

[0011] Step 1: Construction of K. xylinus gene knockout engineering bacteria △acsC_132:

[0012] 1.1) Construct a knockout fragment △acsC_1-C containing the upstream and downstream homologous arms of the acsC_1 gene and the chloramphenicol resistance gene, and prepare K.xylinus ATCC 53524 electroporation competent cells; electroporate the knockout fragment into the competent cells and sequence and verify, and obtain the K.xylinus engineered bacteria △acsC_1 with a single gene knockout of acsC_1.

[0013] 1.2) Construct a knockout fragment △acsC_3-A containing the upstream and downstream homologous arms of the acsC_3 gene and the ampicillin resistance gene, and prepare △acsC_1-C electroporation competent cells; electroporate the knockout fragment into competent cells and sequence and verify, and obtain the engineered bacteria △acsC_13 with double gene knockout of acsC_1 and acsC_3.

[0014] 1.3) Construct a knockout fragment △acsC_2-K containing the upstream and downstream homologous arms of the acsC_2 gene and the kanamycin resistance gene, and prepare △acsC_13 electroporation competent cells; electroporate the knockout fragment into competent cells and sequence and verify, and obtain an engineered strain with three genes knocked out, namely △acsC_132, namely, acsC_3 and acsC_2.

[0015] Step 2: Construction of K. xylinus gene overexpression engineering bacteria △acsC_132+bglB_2:

[0016] 2.1) Construction of auxiliary plasmid p331-P J23104 , p331-Amp and p331-Spc, of which p331-Spc plasmid uses spectinomycin resistance as a selection marker, and its promoter, RBS and terminator are P J23104 , BBa_B0034, and lambdaT0.

[0017] 2.2) Using the genome of K. xylinus ATCC 53524 as a template, PCR amplification was performed to obtain the bglB_2 gene fragment; using the p331-Spc plasmid as a template, PCR amplification was performed to obtain the plasmid vector fragment; The overexpression plasmid p331-bglB_2 was constructed using a PCR one-step directional cloning kit.

[0018] 2.3) Prepare △acsC_132 electroporation competent cells, electroporate the overexpression plasmid into the competent cells and verify by sequencing to obtain the engineered bacteria △acsC_132+bglB_2 overexpressing the bglB_2 gene.

[0019] The nucleotide sequence of the acsC_1 gene is shown in the sequence listing SEQ ID NO.1, the nucleotide sequence of the acsC_2 gene is shown in the sequence listing SEQ ID NO.2, the nucleotide sequence of the acsC_3 gene is shown in the sequence listing SEQ ID NO.3, and the nucleotide sequence of the bglB_2 gene is shown in the sequence listing SEQ ID NO.4.

[0020] The antibiotic resistance genes in the knockout fragment and the overexpression plasmid are ampicillin resistance gene, chloramphenicol resistance gene, kanamycin resistance gene and spectinomycin resistance gene.

[0021] The present invention relates to an application based on the above-mentioned xylogluconic acid acetobacter △acsC_132+bglB_2, which is realized by dynamically fermenting the strain, and the intracellular BC yield is significantly improved.

[0022] The dynamic fermentation is carried out by the following method:

[0023] 1) Strain activation: streak the control bacteria and engineered bacteria frozen at -80°C onto HS solid plates containing corresponding resistance and culture at 30°C for 1-2 days.

[0024] 2) Seed culture: scrape a loop of colonies from the plate into a 250 mL conical flask containing 30 mL HS liquid culture medium (add corresponding resistance, K. xylinus ATCC 53524 needs to be supplemented with 5 U / mL cellulase), and culture overnight at 30°C and 180 rpm.

[0025] 3) Dynamic fermentation: Determine the OD of the seed bacteria 600 , according to the initial OD 600 The inoculum size was 0.04 (the seed solution of K. xylinus ATCC 53524 needed to be centrifuged at 3000 g for 10 min to remove the culture medium containing cellulase), and was transferred to a 250 mL fermentation bottle containing 50 mL HS liquid culture medium, and cultured at 30°C and 180 rpm for 2-5 days.

[0026] The intracellular BC is purified and determined by the following method:

[0027] 1) Bacteria collection: Determine the OD of the engineered bacteria after 2-5 days of fermentation 600 , take the bacterial volume with OD=20-50 into a 15mL centrifuge tube and centrifuge at 6000g for 10min.

[0028] 2) Disrupt cells and remove soluble sugars: add 5 mL of 80% ethanol solution to a 15 mL centrifuge tube, incubate at 100°C in a water bath for 15-30 min, and centrifuge at 6000 g for 10 min; remove the supernatant, add another 5 mL of 80% ethanol solution to the precipitate, repeat the water bath 2-3 times, centrifuge at 6000 g for 10 min to remove soluble reducing sugars and polysaccharides in the cells, and collect the precipitate.

[0029] 3) Protein removal: transfer the precipitate to a 1.5 mL centrifuge tube, wash with distilled water for 3 times, centrifuge at 6000 g for 10 min to remove residual ethanol; take 2 g of protease powder, dilute to 100 mL of distilled water, and prepare 20 mg / mL protease solution; add 1 mL of the prepared protease solution to the precipitate, incubate at 55°C for 1-5 h, centrifuge at 6000 g for 10 min to remove protein, and collect the precipitate.

[0030] 4) Removal of lipids: Add 1 mL of chloroform-methanol (v / v=1:1) to the precipitate, oscillate on an oscillator at 1000 rpm for 15-30 min; centrifuge at 6000 g for 10 min, add 1 mL of methanol to the precipitate, wash once, wash once with 1 ml of acetone, wash 2-3 times with 1 mL of distilled water, centrifuge at 6000 g for 10 min to remove lipids, and the precipitate is used for determination of intracellular BC content.

[0031] 5) Determination of intracellular BC content: add 0.5 mL of distilled water to the precipitate, place it in an ice-water mixture, and slowly add 0.75 mL of concentrated sulfuric acid. Mix well and place in an ice-water bath for 30 min; centrifuge at 8000 g, 4 °C for 10 min, take the supernatant and dilute it to a suitable multiple for testing; prepare glucose standard solutions with concentrations of 0.005, 0.01, 0.02, 0.04, 0.06, 0.08, and 0.1 mg / mL and 0.2% anthrone reagent (2 g anthrone dissolved in 100 mL of concentrated sulfuric acid); take 200 μL glucose standard solution, distilled water and sample supernatant were added to a 1.5mL centrifuge tube; 400μL anthrone reagent was added, mixed and placed in a boiling water bath for 10min, taken out and cooled to room temperature, 200μL was aspirated on a 96-well plate, and the absorbance at 620nm was measured with an ELISA reader; a standard curve was drawn based on the concentration (x, mg / mL) and absorbance (y, △A) of the standard, and the concentration (x, mg / mL) of the sample was calculated, and the BC content per unit cell dry weight (mg / gDCW) = x×1.25÷1.11÷M. Among them, the volume of cellulose extract is 1.25mL (0.5mL distilled water + 0.75mL concentrated sulfuric acid), the glucose content is converted to the cellulose content constant of 1.11 (111μg glucose is equivalent to 100μg cellulose when the anthrone reagent is used for color development), and M is the measured cell dry weight of OD=20-50. BRIEF DESCRIPTION OF THE DRAWINGS

[0032] Figure 1 A schematic diagram of the process for optimizing the intracellular synthesis of bacterial nanocellulose;

[0033] Figure 2 Schematic diagram of PCR identification of K.xylinus gene knockout and overexpression engineering bacteria;

[0034] Figure 3 Schematic diagram of the growth curve of K. xylinus gene knockout engineering bacteria △acsC_132;

[0035] Figure 4 Schematic diagram of intracellular BC production of K. xylinus gene overexpression engineering bacteria △acsC_132+bglB_2;

[0036] Figure 5 Schematic diagram of intracellular BC production in K. xylinus gene overexpression engineered bacteria △acsC_132+bglB_2. DETAILED DESCRIPTION

[0037] like Figure 1 As shown, a method for optimizing the intracellular synthesis of bacterial nanocellulose involved in this embodiment includes:

[0038] Step 1: construct K. xylinus gene knockout engineering bacteria △acsC_132, specifically including:

[0039] 1.1) Construction of K. xylinus engineered bacteria △acsC_1 with single acsC_1 gene knockout, specifically including:

[0040] a) Construction of knockout fragment △acsC_1-C: Using K.xylinus ATCC 53524 genome as template and W1-F / W1-R and W2-F / W2-R as primers, PCR amplification was performed to obtain the upstream and downstream homology arm fragments of acsC_1, acsC_1-U and acsC_1-D, with fragment sizes of 1074 bp and 1131 bp, respectively; using pSEVA331Bb plasmid as template and W3-F / W3-R as primers, PCR amplification was performed to obtain the resistance gene fragment acsC_1-C, with a fragment size of 931 bp; using acsC_1-U, acsC_1-D and acsC_1-C fragments as templates and W1-F and W2-R as primers, PCR fusion was performed to obtain △acsC_1-C, with a fragment size of 3096 bp.

[0041] b) Preparation of K.xylinusATCC 53524 electrocompetent cells: Take out K.xylinusATCC 53524 strain from -80℃ freezer, streak on HS solid medium, and culture at 30℃ for 1-2 days for activation; scrape a loop of colonies from the plate into a 250mL conical flask filled with 30mL HS liquid medium, add 5U / L cellulase, and culture at 30℃, 180rpm overnight; the seed solution is heated to 400℃ at the initial OD 600 The inoculum volume of 0.04 was transferred to a 250 mL conical flask containing 50 mL HS liquid medium, and 5 U / L cellulase was added. The culture was expanded at 30 ° C and 180 rpm. 600 When the cell density reaches 0.4-0.7, collect the cells by centrifugation at 3000 g for 10 min at 4°C, and then wash twice with 20 mL of 0.1 mM HEPES sterile buffer; finally, add about 1 mL of 15% sterile glycerol solution to the collected cells of about 200 mL of fermentation broth, and dispense into 1.5 mL EP tubes, 100 μL per tube, for direct electroporation or storage in a -80°C refrigerator.

[0042] c) Electrotransformation of the knockout fragment △acsC_1-C: Add the △acsC_1-C knockout fragment obtained in a) to 100 μL of K.xylinusATCC 53524 competent cells prepared in b), and place on ice for 10-20 min; transfer the mixed solution to a 1 mm electroporation cup, and electrotransform in a Bio-rad electroporator with the voltage set to 2.5 kV, the resistance set to 200 Ω, and the capacitance set to 25 μF; immediately after electrotransformation, add 1 mL of HS liquid culture medium containing 5 U / L cellulase, and resuscitate at 30°C and 180 rpm for 4-16 h; after centrifugation at 3000 g for 2 min, apply the bacterial solution to a HS solid plate containing 340 μg / mL chloramphenicol resistance, and culture at 30°C for 2-5 days.

[0043] d) Verification of △acsC_1 engineered bacteria: randomly pick multiple transformants and place them in 1.5mL EP tubes containing 340μg / mL chloramphenicol resistance, 5U / L cellulase and 50μL HS medium, and culture them at 30℃ for 1-2 days; use S1-F / S1-R as primers, and verify the knockout of acsC_1 gene by PCR of bacterial liquid: Figure 2As shown, with K.xylinus ATCC 53524 strain (lane 1, 6182bp) as the control, the transformant with successful acsC_1 knockout had a band at 3277bp (lane 2); using S1-F / S1-R / S2-F / S2-R as primers, it was sent to Qingke Biotechnology Co., Ltd. for sequencing, and the K.xylinus engineered bacteria △acsC_1 with single gene knockout of acsC_1 was successfully obtained; 50μL of the correctly sequenced bacterial solution was spread on a HS solid plate containing 340μg / mL chloramphenicol resistance and cultured at 30℃ for 1-2 days.

[0044] The primers required for the above are as follows: Primer name Primer (5'-3') Serial number W1-F gctcatgcagcatccgttcca Seq ID No.5 W1-R gtgccgatcacgtgctgcctgccgggcg Seq ID No.6 W2-F ggcgtcagcctacactcaaaccggggcagg Seq ID No.7 W2-R gcctgatctgcaatgacgatacca Seq ID No.8 W3-F aggcagcacgtgatcggcacgtaagagg Seq ID No.9 W3-R tttgagtgtaggctgacgccgttggat Seq ID No.10 S1-F gccttgccattgcccttgtg Seq ID No.11 S1-R cgtagctgcggcatgtggtt Seq ID No.12 S2-F agacggtgagctggtgatatgg Seq ID No.13 S2-R tcaccgtaacacgccacatcttg Seq ID No.14

[0045] 1.2) Construction of K. xylinus engineered bacteria △acsC_13 with double knockout of acsC_1 and acsC_3, specifically including:

[0046] a) Construction of knockout fragment △acsC_3-A: Using K.xylinus ATCC 53524 genome as template and W4-F / W4-R and W5-F / W5-R as primers, PCR amplification was performed to obtain the upstream and downstream homology arm fragments of acsC_3, acsC_3-U and acsC_3-D, with fragment sizes of 999 bp and 1126 bp, respectively; using pUC19 plasmid as template and W6-F / W6-R as primers, PCR amplification was performed to obtain the resistance gene fragment acsC_3-A, with a fragment size of 1136 bp; using acsC_3-U, acsC_3-D and acsC_3-A fragments as templates and W4-F and W5-R as primers, PCR fusion was performed to obtain △acsC_3-A, with a fragment size of 3221 bp.

[0047] b) Preparation of △acsC_1 electroporation competent cells and electroporation of knockout fragment △acsC_3-A: Prepare electroporation competent cells from K.xylinus engineered bacteria △acsC_1 with single acsC_1 gene knockout according to step b) of 1.1); electroporate the knockout fragment △acsC_3-A into △acsC_1 competent cells according to step c) of 1.1); after recovery, spread the bacterial solution on a solid HS plate containing 340 μg / mL chloramphenicol resistance and 100 μg / mL ampicillin resistance, and culture at 30°C for 2-5 days.

[0048] c) Verification of △acsC_13 engineered bacteria: randomly pick multiple transformants and place them in 50 μL HS medium containing 340 μg / mL chloramphenicol resistance, 100 μg / mL ampicillin resistance and 5 U / L cellulase, and culture at 30°C for 1-2 days; use S3-F / W5-R as primers, and verify the knockout of acsC_3 gene by bacterial liquid PCR: Figure 1 As shown, with the △acsC_1 strain (lane 3, 6184bp) as the control, the transformant with successful knockout of acsC_3 had a band at 3361bp (lane 4); using S3-F / W5-R / S4-F / S4-R as primers, it was sent to Qingke Biotechnology Co., Ltd. for sequencing, and the K.xylinus engineered bacteria △acsC_13 with double gene knockout of acsC_1 and acsC_3 was successfully obtained; about 50μL of the correctly sequenced bacterial solution was spread on a HS solid plate containing 340μg / mL chloramphenicol resistance and 100μg / mL ampicillin resistance, and cultured at 30℃ for 1-2 days.

[0049] The primers required for the above are as follows: Primer name Primer (5'-3') Serial number W4-F atgacagcgtgcagaagc Seq ID No.15 W4-R aaacaaataggggttccgcggatcacgttctctgcctttcttcc Seq ID No.16 W5-F gaaaagatcaaaggatcttcatgacaactttgaacgcaaaac Seq ID No.17 W5-R cgcgcccgatcatgacacc Seq ID No.18 W6-F cgcggaacccctatttgt Seq ID No.19 W6-R gaagatcctttgatcttttct Seq ID No.20 S3-F accgccaggaccgattgt Seq ID No.21 S4-F tgctgccataaccatgagtgat Seq ID No.22 S4-R caacgatcaaggcgagttacat Seq ID No.23

[0050] 1.3) Construction of K. xylinus engineered bacteria with knockout of three genes: acsC_1, acsC_3 and acsC_2 △acsC_132, specifically including:

[0051] a) Construction of knockout fragment △acsC_2-K: Using K.xylinus ATCC 53524 genome as template and W7-F / W7-R and W8-F / W8-R as primers, PCR amplification was performed to obtain the upstream and downstream homology arm fragments of acsC_2, acsC_2-U and acsC_2-D, with fragment sizes of 982 bp and 1077 bp, respectively; using pET28a plasmid as template and W9-F / W9-R as primers, PCR amplification was performed to obtain the resistance gene fragment acsC_2-K, with a fragment size of 1049 bp; using acsC_2-U, acsC_2-D and acsC_2-K fragments as templates and W7-F and W8-R as primers, PCR fusion was performed to obtain △acsC_2-K, with a fragment size of 3068 bp.

[0052] b) Preparation of △acsC_13 electroporation competent cells and electroporation of knockout fragment △acsC_2-K: Electroporation competent cells were prepared according to step b) of 1.1) using the engineered bacteria △acsC_13 with double knockout of acsC_1 and acsC_3; The △acsC_2-K knockout fragment was electroporated into △acsC_13 competent cells according to step c) of 1.1). After recovery, the bacterial solution was spread on a solid HS plate containing 340 μg / mL chloramphenicol resistance, 100 μg / mL ampicillin resistance and 40 μg / mL kanamycin resistance, and cultured at 30°C for 2-5 days.

[0053] c) Verification of △acsC_132 engineered bacteria: randomly select multiple transformants and place them in 50 μL HS medium containing 340 μg / mL chloramphenicol resistance, 100 μg / mL ampicillin resistance, 40 μg / mL kanamycin resistance and 5U / L cellulase, and culture at 30°C for 1-2 days; use S5-F / W8-R as primers, and verify the knockout of acsC_2 gene by PCR in bacterial liquid: Figure 1 As shown, with the △acsC_13 strain (5,6241bp) as the control, the transformant with successful knockout of acsC_2 had a band at 3466bp (lane 6); using S5-F / W8-R / S6-F / S6-R as primers, it was sent to Qingke Biotechnology Co., Ltd. for sequencing, and the engineered bacteria △acsC_132 with three genes knocked out of acsC_1, acsC_3 and acsC_2 were successfully obtained; about 50μL of the correctly sequenced bacterial solution was spread on a HS solid plate containing 340μg / mL chloramphenicol resistance, 100μg / mL ampicillin resistance and 40μg / mL kanamycin resistance, and cultured at 30℃ for 1-2 days.

[0054] The required primers are shown in the following table: Primer name Primer (5'-3') Serial number W7-F tgcctatccgctcgtgacct Seq ID No.24 W7-R AAGGATCTTCggtcacaggtcgcccgtc Seq ID No.25 W8-F GTGCCACCTGgaaggctgctggaaactgc Seq ID No.26 W8-R cgccagaactgacatggaggaa Seq ID No.27 W9-F acctgtgaccGAAGATCCTTTGATCTTTTCTACGG Seq ID No.28 W9-R agcagccttcCAGGTGGCACTTTTCGGGGAA Seq ID No.29 S5-F catgatggtttcggcacgatcc Seq ID No.30 S6-F GTTGATGCGCTGGCAGTG Seq ID No.31 S6-R CTCGCATCAACCAAACCG Seq ID No.32

[0055] Step 2, constructing K. xylinus gene overexpression engineering bacteria △acsC_132+bglB_2, specifically comprising:

[0056] 2.1) Helper plasmid p331-P J23104 , p331-Amp and p331-Spc, specifically including:

[0057] a) Using pSEVA331Bb plasmid as template and W10-F and W10-R as primers, PCR amplification was performed to obtain the inserted P J23104 The promoter and RBS (BBa_B0034), the plasmid vector fragment F-p331 with MCS deleted, the fragment size is 2776bp; after gel excision and recovery, PCR one-step directional cloning kit to complete p331-P J23104 Construction of plasmids.

[0058] b) p331-P J23104The plasmid was used as a template and W11-F and W11-R were used as primers to amplify the plasmid vector fragment F-p331-P. J23104 , the fragment size is 2033bp; using pUC19 plasmid as template, W6-F and W12-R as primers, PCR amplification obtained the resistance fragment F-Amp, the fragment size is 966bp; after gel excision and recovery, The p331-Amp plasmid was constructed using a PCR one-step directional cloning kit.

[0059] c) Using p331-Amp plasmid as template and W13-F and W13-R as primers, PCR amplification was performed to obtain the plasmid vector fragment F-p331-P J23104 , the fragment size is 2098bp; using pTKRED plasmid as template, W14-F and W14-R as primers, PCR amplification obtained the resistance fragment F-Spc, the fragment size is 832bp; after gel excision and recovery, The p331-Spc plasmid was constructed using a PCR one-step directional cloning kit.

[0060] 2.2) Construction of overexpression plasmid p331-bglB_2, specifically including:

[0061] a) Using the genome of K. xylinus ATCC 53524 as a template and W15-F / W15-R as primers, PCR amplification was performed to obtain a gene fragment F-bglB_2 with a fragment size of 2248 bp.

[0062] b) Using p331-Spc plasmid as template and W16-F and W16-R as primers, PCR amplification was performed to obtain the plasmid vector fragment F-p331-Spc with a fragment size of 2906 bp.

[0063] c) By The PCR one-step directional cloning kit was used to connect the F-p331-Spc plasmid vector fragment with the F-bglB_2 gene fragment. Using S7-F / S7-R / S8-F / S8-R as primers, the fragment was sent to Qingke Biotechnology Co., Ltd. for sequencing, and the p331-bglB_2 overexpression plasmid was successfully obtained.

[0064] 2.3) Preparation of △acsC_132 electroporation competent cells and electroporation of overexpression plasmids: The engineered bacteria △acsC_132 with triple knockout of acsC_1, acsC_3 and acsC_2 were used to prepare electroporation competent cells according to step b) of 1.1); the p331-bglB_2 overexpression plasmid was electroporated into △acsC_132 competent cells according to step c) of 1.1); after recovery, the bacterial solution was applied to a solid HS plate containing 340 μg / mL chloramphenicol resistance, 100 μg / mL ampicillin resistance, 40 μg / mL kanamycin resistance and 100 μg / mL spectinomycin resistance, and cultured at 30°C for 2-5 days.

[0065] 2.5) Verification of △acsC_132+bglB_2 engineered bacteria: randomly select multiple transformants and place them in 50 μL HS medium containing 340 μg / mL chloramphenicol resistance, 100 μg / mL ampicillin resistance, 40 μg / mL kanamycin resistance, 100 μg / mL spectinomycin resistance and 5 U / L cellulase, and culture at 30°C for 1-2 days; use S9-F / S9-R as primers to verify the overexpression of the plasmid by PCR: Figure 1 As shown, with the wild-type strain (lane 7, 0 bp) as the control, the transformant that successfully overexpressed the bglB_2 gene had a band at 4527 bp (lane 8); S7-F / S7-R / S8-F / S8-R were used as primers again and sent to Qingke Biotechnology Co., Ltd. for sequencing, and the bglB_2 gene overexpressing engineered bacteria △acsC_132+bglB_2 were successfully obtained; about 50 μL of the correctly sequenced bacterial solution was spread on a HS solid plate containing 340 μg / mL chloramphenicol resistance, 100 μg / mL ampicillin resistance, 40 μg / mL kanamycin resistance and 100 μg / mL spectinomycin resistance, and cultured at 30°C for 1-2 days.

[0066] The required primers are shown in the following table:

[0067] Step 3, dynamic fermentation and growth curve determination of the engineered bacteria △acsC_132, specifically comprising:

[0068] 3.1) Strain activation: The control strain K. xylinus ATCC 53524 and the engineered strain ΔacsC_132 stored at -80°C were streaked onto HS solid plates containing the corresponding resistances and cultured at 30°C for 1-2 days.

[0069] 3.2) Seed culture: scrape a loop of colonies from the plate into a 250 mL conical flask containing 30 mL HS liquid medium (with corresponding resistance, K. xylinus ATCC 53524 with 5 U / mL cellulase), and culture overnight at 30°C and 180 rpm.

[0070] 3.3) Dynamic fermentation: Centrifuge at 3000g for 10 min, collect the cells and remove the medium containing cellulase, suspend the cells with appropriate amount of sterile water, and ferment according to the initial OD 600 The inoculum size was 0.04, which was transferred to a 250 mL fermentation bottle containing 50 mL HS liquid medium and cultured at 30°C and 180 rpm for 5 days.

[0071] HS medium consisted of 20 g / L glucose, 5 g / L peptone, 5 g / L yeast powder, 6.8 g / L Na2HPO4·12H2O and 1.15 g / L citric acid monohydrate, pH = 6.0.

[0072] 3.4) Growth curve determination: Take three parallel samples of K. xylinus ATCC 53524 and ΔacsC_132 engineered bacteria every 10-24 hours and measure the OD 600 And draw a growth curve. Figure 3 As shown, compared with K. xylinus ATCC 53524, the cell growth of the engineered bacteria △acsC_132 increased by about 1 times, and its growth curve was specifically measured by the following method:

[0073] a) The cell growth of △acsC_132+bglB_2 was determined by turbidimetry. The fermentation broth was diluted to an appropriate multiple and the optical density (OD) of the bacterial suspension was determined by a spectrophotometer. 600 And make a growth curve.

[0074] 2) First, use cellulase to enzymolyze the extracellular BC synthesized by K.xylinusATCC 53524 strain, and then use turbidimetry to determine its cell growth. Accurately weigh 21.01g of monohydrated citric acid and 29.41g of sodium citrate, and dilute them to 1L of distilled water respectively; take 828mL of 0.1mol / L citric acid solution and 972mL of 0.1mol / L sodium citrate solution, mix them evenly, and prepare a citric acid-sodium citrate buffer solution with a pH of 4.8; take 18g of cellulase (McLean, 10000U / g) and dissolve it in 1.8L of buffer solution, and filter it with a 0.22μm filter membrane to remove the insoluble matter in the cellulase. 50 mL of cellulase solution was added to a 250 mL conical flask containing 50 mL of fermentation broth to make a final cellulase concentration of 50 U / mL. The fermentation broth was subjected to enzymolysis at 55°C and 180 rpm for 12-24 h. For the fermentation broth that was not fully hydrolyzed, it was centrifuged at 3000 g for 10 min. 25 mL of cellulase solution and 25 mL of distilled water were added to the precipitate. The enzymolysis was continued at 55°C and 180 rpm. The BC enzymolysis was observed under a microscope until it was completely hydrolyzed. The OD was measured. 600 And make a growth curve.

[0075] Step 4, dynamic fermentation of the engineered bacteria △acsC_132+bglB_2 and purification and determination of intracellular BC, specifically including:

[0076] 4.1) Strain activation: streak the -80°C frozen △acsC_132 and △acsC_132+bglB_2 engineered bacteria onto HS solid plates containing corresponding resistances and culture at 30°C for 1-2 days.

[0077] 4.2) Seed culture: scrape a loop of colonies from the plate into a 250 mL conical flask filled with 30 mL HS liquid culture medium (added with corresponding resistance), and culture overnight at 30°C and 180 rpm.

[0078] 4.3) Dynamic fermentation: Determination of seed cell mass OD 600 , according to the initial OD 600 The inoculum size was 0.04, which was transferred to a 250 mL fermentation bottle containing 50 mL HS liquid medium and cultured at 30°C and 180 rpm for 3 days.

[0079] 4.4) Purification and determination of intracellular BC, specifically including:

[0080] a) Bacteria collection: Determine the OD of △acsC_132 and △acsC_132+bglB_2 engineered bacteria at 73.5 h 600 , take the bacterial amount of OD=20 (0.000225gDCW / OD) into 15mL centrifuge tubes and centrifuge at 6000g for 10min.

[0081] b) Disrupt cells and remove soluble sugars: add 5 mL of 80% ethanol solution to a 15 mL centrifuge tube, incubate at 100°C in a water bath for 20 min, and centrifuge at 6000 g for 10 min. Remove the supernatant, add another 5 mL of 80% ethanol solution to the precipitate, repeat the water bath for 3 times, centrifuge at 6000 g for 10 min to remove soluble reducing sugars and polysaccharides in the cells, and collect the precipitate.

[0082] c) Protein removal: transfer the precipitate to a 1.5 mL centrifuge tube, wash with distilled water for 3 times, centrifuge at 6000 g for 10 min to remove residual ethanol; take 2 g of protease powder, dilute to 100 mL of distilled water, and prepare 20 mg / mL protease solution; add 1 mL of the prepared protease solution to the precipitate, incubate at 55°C for 2 h, centrifuge at 6000 g for 10 min to remove protein, and collect the precipitate.

[0083] d) Removal of lipids: add 1 mL of chloroform-methanol (v / v=1:1) to the precipitate, oscillate on an oscillator at 1000 rpm for 15 min; centrifuge at 6000 g for 10 min, add 1 mL of methanol to the precipitate, wash once, wash once with 1 ml of acetone, wash twice with 1 mL of distilled water, centrifuge at 6000 g for 10 min to remove lipids, and the precipitate is used for determination of intracellular BC content.

[0084] e) Determination of intracellular BC content: add 0.5 mL of distilled water to the precipitate, place it in an ice-water mixture, and slowly add 0.75 mL of concentrated sulfuric acid. Mix well and place in an ice-water bath for 30 min; centrifuge at 8000 g, 4 ° C for 10 min, and take the supernatant for measurement; prepare glucose standard solutions with concentrations of 0.005, 0.01, 0.02, 0.04, 0.06, 0.08, and 0.1 mg / mL and 0.2% anthrone reagent (2 g anthrone dissolved in 100 mL of concentrated sulfuric acid); take 200 μL of glucose and 100 μL of anthrone reagent respectively. Add glucose standard solution, distilled water and sample supernatant to a 1.5mL centrifuge tube; add 400μL anthrone reagent, mix well and place in a boiling water bath for 10min, take out and cool to room temperature, aspirate 200μL in a 96-well plate, and measure the absorbance at 620nm with an enzyme marker; draw a standard curve based on the concentration (x, mg / mL) and absorbance (y, △A) of the standard, and calculate the concentration of the sample (x, mg / mL), the BC content per unit cell dry weight (mg / gDCW) = x×1.25÷1.11÷M. Among them, the volume of cellulose extract is 1.25mL (0.5mL distilled water + 0.75mL concentrated sulfuric acid), the glucose content is converted to the cellulose content constant of 1.11 (111μg glucose is equivalent to 100μg cellulose when colored with anthrone reagent), and M is the measured cell dry weight of OD=20 (0.0045gDCW). Figure 4As shown, compared with the △acsC_132 engineered bacteria, the intracellular BC content of the △acsC_132+bglB_2 engineered bacteria increased by 209%.

[0085] Step 5, dynamic fermentation of the engineered bacteria △acsC_132+bglB_2 and purification and determination of intracellular BC, specifically including:

[0086] 5.1) The △acsC_132 and △acsC_132+bglB_2 engineered bacteria were subjected to dynamic fermentation according to steps 4.1), 4.2) and 4.3) of step 4.

[0087] 5.2) Purification and determination of intracellular BC, specifically including:

[0088] a) Bacteria collection: Determine the OD of △acsC_132 and △acsC_132+bglB_2 engineered bacteria at 72 hours 600 , take the bacterial amount of OD=50 (0.000225gDCW / OD) into 15mL centrifuge tubes and centrifuge at 6000g for 10min.

[0089] b) Disrupt cells and remove soluble sugars: add 5 mL of 80% ethanol solution to a 15 mL centrifuge tube, incubate at 100°C in a water bath for 15 min, and centrifuge at 6000 g for 10 min. Remove the supernatant, add another 5 mL of 80% ethanol solution to the precipitate, repeat the water bath twice, centrifuge at 6000 g for 10 min to remove soluble reducing sugars and polysaccharides in the cells, and collect the precipitate.

[0090] c) Protein removal: transfer the precipitate to a 1.5 mL centrifuge tube, wash twice with distilled water, centrifuge at 6000 g for 10 min to remove residual ethanol; take 2 g of protease powder, dilute to 100 mL of distilled water, and prepare 20 mg / mL protease solution; add 1 mL of the prepared protease solution to the precipitate, incubate at 55°C for 1 h, centrifuge at 6000 g for 10 min to remove protein, and collect the precipitate.

[0091] d) Removal of lipids: add 1 mL of chloroform-methanol (v / v=1:1) to the precipitate, oscillate on an oscillator at 1000 rpm for 15 min; centrifuge at 6000 g for 10 min, add 1 mL of methanol to the precipitate, wash once, wash once with 1 ml of acetone, wash twice with 1 mL of distilled water, centrifuge at 6000 g for 10 min to remove lipids, and the precipitate is used for determination of intracellular BC content.

[0092] e) Determination of intracellular BC content: add 0.5 mL of distilled water to the precipitate, place it in an ice-water mixture, and slowly add 0.75 mL of concentrated sulfuric acid. After mixing, place it in an ice-water bath for 30 min; centrifuge at 8000 g, 4°C for 10 min, take the supernatant and dilute it 2 times for testing; prepare glucose standard solutions with concentrations of 0.005, 0.01, 0.02, 0.04, 0.06, 0.08, and 0.1 mg / mL and 0.2% anthrone reagent (2 g anthrone dissolved in 100 mL of concentrated sulfuric acid); take 200 μL of each Glucose standard solution, distilled water and sample supernatant are placed in a 1.5mL centrifuge tube; 400μL of anthrone reagent is added, mixed and placed in a boiling water bath for 10 minutes, taken out and cooled to room temperature, 200μL is pipetted into a 96-well plate, and the absorbance at 620nm is measured with an enzyme marker; a standard curve is drawn according to the concentration (x, mg / mL) and absorbance (y, △A) of the standard, and the concentration of the sample (x, mg / mL) is calculated, and the BC content per unit cell dry weight (mg / gDCW) = x×1.25÷1.11÷M*2. Among them, the volume of cellulose extract is 1.25mL (0.5mL distilled water + 0.75mL concentrated sulfuric acid), the glucose content is converted to the cellulose content constant of 1.11 (111μg glucose is equivalent to 100μg cellulose when colored with anthrone reagent), M is the measured cell dry weight of OD=50 (0.01125gDCW), and 2 is the dilution factor. Figure 5 As shown, compared with the △acsC_132 engineered bacteria, the intracellular BC content of the △acsC_132+bglB_2 engineered bacteria increased by 176%.

[0093] Compared with the existing technology, this method completely blocks the secretion of extracellular BC by knocking out three acsC genes, and increases the cell growth by about one-fold; overexpression of the bglB_2 gene increases the intracellular BC production, up to more than two-fold; ethanol extraction and anthrone sulfuric acid method are used to purify and determine intracellular BC, avoiding the problem of BC degradation by the traditional NaOH alkaline boiling method.

[0094] The above-mentioned specific implementation can be partially adjusted in different ways by those skilled in the art without departing from the principle and purpose of the present invention. The protection scope of the present invention shall be based on the claims and shall not be limited by the above-mentioned specific implementation. Each implementation scheme within its scope shall be subject to the constraints of the present invention.

Claims

1. An engineered bacterium for producing intracellular bacterial nanocellulose, It is characterized in that Specifically: Komagataeibacter xylinus △acsC_132+bglB_2, with the deposit number of CGMCC No.31120, currently deposited in the Institute of Microbiology, Chinese Academy of Sciences, with a deposit date of July 1, 2024; The xylinacetobacter △acsC_132+bglB_2 no longer secretes BC outside the cell.

2. A method for producing the xylindoleacetobacter ΔacsC_132+bglB_2 according to claim 1, It is characterized in that Using K. xylinus ATCC 53524 as the starting strain, the △acsC_132 strain was constructed by knocking out the acsC_1, acsC_2 and acsC_3 genes; and then based on △acsC_132, the bglB_2 gene was overexpressed to construct the strain.

3. The implementation method according to claim 2, Its characteristics are that include: Step 1: Construction of K. xylinus gene knockout engineering bacteria △acsC_132: (1.1) constructing a knockout fragment △acsC_1-C containing the upstream and downstream homologous arms of the acsC_1 gene and the chloramphenicol resistance gene, and preparing K.xylinus ATCC 53524 electroporation competent cells; electroporating the knockout fragment into competent cells and sequencing verification to obtain K.xylinus engineered bacteria △acsC_1 with a single gene knockout of acsC_1; (1.2) constructing a knockout fragment △acsC_3-A containing the upstream and downstream homologous arms of the acsC_3 gene and the ampicillin resistance gene, and preparing △acsC_1-C electroporation competent cells; electroporating the knockout fragment into competent cells and sequencing verification to obtain the engineered bacteria △acsC_13 with double gene knockout of acsC_1 and acsC_3; (1.3) constructing a knockout fragment △acsC_2-K containing the upstream and downstream homologous arms of the acsC_2 gene and the kanamycin resistance gene, and preparing △acsC_13 electroporation competent cells; electroporating the knockout fragment into competent cells and sequencing verification to obtain an engineering strain with three genes knocked out, namely △acsC_132; Step 2: Construction of K. xylinus gene overexpression engineering bacteria △acsC_132+bglB_2: (2.1) Construction of auxiliary plasmid p331-P J23104 , p331-Amp and p331-Spc, of which p331-Spc plasmid uses spectinomycin resistance as a selection marker, and its promoter, RBS and terminator are P J23104 , BBa_B0034 and lambdaT0; (2.2) Using the genome of K.xylinus ATCC 53524 as a template, PCR amplification was performed to obtain the bglB_2 gene fragment; using the p331-Spc plasmid as a template, PCR amplification was performed to obtain the plasmid vector fragment; and the overexpression plasmid p331-bglB_2 was constructed using a one-step directional cloning kit; (2.3) Prepare △acsC_132 electroporation competent cells, electroporate the overexpression plasmid into the competent cells and verify by sequencing to obtain the engineered bacteria △acsC_132+bglB_2 overexpressing the bglB_2 gene.

4. The implementation method according to claim 2 or 3, Its characteristics are: The nucleotide sequence of the acsC_1 gene is shown in the sequence listing SEQ ID NO.1, the nucleotide sequence of the acsC_2 gene is shown in the sequence listing SEQ ID NO.2, the nucleotide sequence of the acsC_3 gene is shown in the sequence listing SEQ ID NO.3, and the nucleotide sequence of the bglB_2 gene is shown in the sequence listing SEQ ID NO.

4.

5. The implementation method according to claim 2 or 3, Its characteristics are: The antibiotic resistance genes in the knockout fragment and the overexpression plasmid are ampicillin resistance gene, chloramphenicol resistance gene, kanamycin resistance gene and spectinomycin resistance gene.

6. An application of Gluconobacter xylinacetoacetobacter △acsC_132+bglB_2 prepared by the method according to claim 1 or claims 2-5, It is characterized in that This is achieved by dynamically fermenting the strain.

7. The use according to claim 6, Its characteristics are: The dynamic fermentation is carried out by the following method: (1) Strain activation: streak the control bacteria and engineered bacteria frozen at -80°C onto HS solid plates containing corresponding resistances and culture at 30°C for 1-2 days. (2) Seed culture: Scrape a loop of colonies from the plate into a 250 mL conical flask containing 30 mL of HS liquid medium (with corresponding resistance added, K. xylinus ATCC 53524 needs to be supplemented with 5 U / mL cellulase) and culture overnight at 30°C and 180 rpm. (3) Dynamic fermentation: Determination of seed cell mass OD 600 , according to the initial OD 600 The inoculum size was 0.04 (the K. xylinus ATCC53524 seed solution needed to be centrifuged at 3000 g for 10 min to remove the culture medium containing cellulase), and was transferred to a 250 mL fermentation bottle containing 50 mL HS liquid culture medium, and cultured at 30°C and 180 rpm for 2-5 days.

8. The use according to claim 7, Its characteristics are: The intracellular BC is purified and determined by the following method: (1) Bacteria collection: Determine the OD of the engineered bacteria after 2-5 days of fermentation 600 , take the bacterial volume with OD=20-50 into a 15mL centrifuge tube and centrifuge at 6000g for 10min; (2) Disrupt cells and remove soluble sugars: Add 5 mL of 80% ethanol solution to a 15 mL centrifuge tube, incubate at 100°C in a water bath for 15-30 min, and centrifuge at 6000 g for 10 min; Remove the supernatant, add 5 mL of 80% ethanol solution to the precipitate, repeat the water bath 2-3 times, centrifuge at 6000 g for 10 min to remove the soluble reducing sugars and polysaccharides in the cells, and collect the precipitate; (3) Protein removal: transfer the precipitate to a 1.5 mL centrifuge tube, wash with distilled water three times, and centrifuge at 6000 g for 10 min to remove residual ethanol; take 2 g of protease powder, dilute to 100 mL of distilled water, and prepare 20 mg / mL protease solution; Add 1 mL of the prepared protease solution to the precipitate, incubate at 55°C for 1-5 h, centrifuge at 6000 g for 10 min to remove the protein, and collect the precipitate; (4) Removal of lipids: Add 1 mL of chloroform-methanol (v / v = 1:1) to the precipitate, oscillate on an oscillator at 1000 rpm for 15-30 min; centrifuge at 6000 g for 10 min, add 1 mL of methanol to the precipitate, wash once, wash once with 1 ml of acetone, wash 2-3 times with 1 mL of distilled water, centrifuge at 6000 g for 10 min to remove lipids, and the precipitate is used for determination of intracellular BC content; (5) Determination of intracellular BC content: add 0.5 mL of distilled water to the precipitate, place it in an ice-water mixture, and slowly add 0.75 mL of concentrated sulfuric acid. After mixing, place it in an ice-water bath for 30 min; centrifuge at 8000 g, 4 °C for 10 min, take the supernatant and dilute it to an appropriate multiple for testing; prepare glucose standard solutions with concentrations of 0.005, 0.01, 0.02, 0.04, 0.06, 0.08, and 0.1 mg / mL and 0.2% anthrone reagent (2 g anthrone dissolved in 100 mL of concentrated sulfuric acid); take 200 μL of glucose standard solution, distilled water, and sample supernatant into 1.5 mL centrifuge tubes respectively; Add 400 μL of anthrone reagent, mix well and place in a boiling water bath for 10 min, take out and cool to room temperature, aspirate 200 μL into a 96-well plate, and measure the absorbance at 620 nm with an enzyme marker; draw a standard curve based on the concentration (x, mg / mL) and absorbance (y, △A) of the standard, and calculate the concentration of the sample (x, mg / mL), BC content per unit cell dry weight (mg / gDCW) = x × 1.25 ÷ 1.11 ÷ M; wherein, the volume of cellulose extract is 1.25 mL (0.5 mL distilled water + 0.75 mL concentrated sulfuric acid), the glucose content is converted to the cellulose content constant of 1.11 (111 μg glucose is equivalent to 100 μg cellulose when developed with anthrone reagent), and M is the measured cell dry weight of OD = 20-50.